fbpx Skip to content
ACT-AD Web Trial Logo_RGB copy
  • About ACT-AD
  • Open Label Extension
  • Study Locations
  • What to Expect
  • Resources
  • News
  • Contact

In the News

The ACT-AD Trial is No Longer Enrolling

Study underway on take-home drug for Alzheimer’s patients

May 17, 2021

Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family.

April 21, 2021

An interview with Dr. Charles Bernick, MD, MPH, a clinical professor at the University of Washington Department of Neurology who has researched Alzheimer’s Disease and treatments for 25 years.

April 21, 2021

Wanted: Mild to Moderate Alzheimer’s Patients for Clinical Trials!

March 16, 2021

Doctors believe a new dementia treatment could regenerate brain cells, and they’re now appealing to Alzheimer’s patients to sign up to a trial.

March 16, 2021

Clinical trials offer hope for local Alzheimer’s patients

March 16, 2021

About ACT-AD
Open Label Extension (ATH-1017 Study 203)
Study Locations
What to Expect
Resources
Contact

Trial sponsored by  
clinicaltrials@athira.com

©2022 Athira Pharma | Privacy Policy

Scroll To Top